# A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

> **NCT06057012** · PHASE2 · COMPLETED · sponsor: **Brii Biosciences Limited** · enrollment: 11 (actual)

## Conditions studied

- Severe Postpartum Depression

## Interventions

- **DRUG:** BRII-296
- **DRUG:** Depo Medrol

## Key facts

- **NCT ID:** NCT06057012
- **Lead sponsor:** Brii Biosciences Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-29
- **Primary completion:** 2024-03-13
- **Final completion:** 2024-03-13
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057012, "A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06057012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*